Avidin Market - By Type (Avidin from Chicken Egg Whites, Streptavidin, Recombinant Avidin), By grade (Food Grade Avidin, Pharmaceutical Grade Avidin, Research Grade Avidin), By Application (Food & Beverage, Pharmaceutical, Research & Biotechnology), Forecast 2023 – 2032

Avidin Market Size

Avidin Market size was valued at over USD 220 million in 2022 and is estimated to exhibit above 6% CAGR from 2023 to 2032. This growth can be attributed to advancements in various biotechnological applications including recombinant DNA technology, gene expression analysis, and protein engineering as well as the rising need for precise & efficient research tools. The increasing demand for diagnostic assays, particularly immunoassays and molecular diagnostics, as a tool for detection & analysis in healthcare & research settings will propel market growth.
 

Avidin plays a vital role in drug discovery & development processes including target identification, screening assays, and drug delivery systems. The rising demand for biological drugs, recombinant proteins, and enzymes will lead to the biopharmaceutical industry expansion, which in turn, will directly assist the market expansion.
 

The production of avidin is a complex & costly procedure, particularly during the use of native sources or while employing recombinant protein expression systems. The high production costs associated with avidin products can limit the affordability & accessibility, leading to challenges for smaller research laboratories and budget-constrained customers. The high affinity of avidin for biotin can also lead to non-specific binding or interference in certain applications, affecting the accuracy & reliability of assays and experimental results.

Avidin, particularly in its native form, can be sensitive to environmental factors such as temperature, pH, and proteases. This sensitivity of avidin may lead to reduced stability and shorter shelf life. The high-end pricing & risks associated with avidin may also deteriorate the acceptance rate, further hampering avidin market growth.
 

COVID-19 Impact

The COVID-19 pandemic led to disruptions in global supply chains, affecting avidin production and distribution. COVID-19 led to closures or restrictions in operations across many research institutions, laboratories, and academic centers. This led to a decline in research activities and the rescheduling of projects. As avidin is widely used in research applications, the reduction in research activities directly impacted product demand. The global economic slowdown induced also impacted several industries including biotechnology and research.
 

Budget restrictions, lower financing capabilities, and market uncertainties contributed to the decline in R&D spending. Reduced investments and the fall in financial resources led to indirect impacts on avidin product demand. The reduction in COVID-19 cases as well as the implementation of subsequent strategies by government & non-government organizations are estimated to drive the market growth.
 

Avidin Market Trends

The avidin industry is expanding, particularly in developing regions. The rising demand for avidin can be attributed to the rising healthcare expenditure, growing research & development activities, and the adoption of sophisticated technologies. In emerging nations, the growing pharmaceutical and biotechnology sectors are projected to open new avenues for avidin manufacturers & suppliers. The integration of technology and automation into various industries, including the automation of avidin-based assays, such as the use of robotic systems for high-throughput screening & analysis, is impacting market growth.
 

The trend toward increased efficiency, accuracy, and productivity is driving the adoption of automated systems that incorporate avidin in various applications. The move toward sustainable agriculture, improved crop yields, and genetically modified organisms is likely to fuel the demand for avidin in agricultural applications. Similarly, the rising focus on animal health & welfare is expected to contribute to the growing use of avidin applications in the veterinary sector.
 

Avidin Market Analysis

Based on type, the avidin market is segmented into avidin from chicken egg whites, streptavidin, and recombinant avidin. The streptavidin segment accounted for nearly USD 150 million in 2022. The high market share of the segment is due to the benefits offered by streptavidin owing to its strong binding affinity for biotin, which forms the basis of the biotin-streptavidin system. This system is highly specific, stable & versatile, and widely utilized in various applications, making it a preferred choice for many researchers & industries.
 

This versatility enables the development of a wide range of streptavidin-based reagents & assays for use in detection, imaging, and protein labeling applications. Recombinant avidin can customize and engineer its properties. This flexibility & ability to optimize avidin properties as per specific needs is augmenting the demand for recombinant avidin. This avidin type can also be engineered to exhibit increased stability including resistance to heat, pH extremes, and proteolytic degradation. Such extended stability is augmenting demand in various industries where stability is crucial, leading to market growth.
 

Based on application, the avidin market is segmented into food grade avidin, pharmaceutical grade avidin, and research grade avidin. The research grade avidin segment captured around 55% of the market share in 2022 and is set to register lucrative pace by 2032 owing to the rise in research & development activities globally. The need for reliable & high-performing reagents in research laboratories is rising the demand for research-grade avidin. The product is often chosen based on its compatibility with established research protocols & methods. Continuous advancements in the biotechnology sector also propel the demand for avidin in various research applications.
 

Based on application, the avidin market is categorized into food & beverage industry, pharmaceutical industry, and research & biotechnology. The research & biotechnology segment held a dominant market share in 2022 and is forecast to attain nearly 6.6% CAGR through 2032. The demand for avidin in assay development is propelled by the rising need for accurate & reliable analytical techniques in research, diagnostics, and drug discovery.
 

The demand for avidin in molecular biology is being propelled by the need for robust & sensitive methods for carrying out nucleic acid analysis & visualization. The demand for avidin in industrial enzyme production is being fueled by the need for efficient enzyme purification & immobilization methods. Thus, the presence of high-quality services and the growing use of avidin in research laboratories to accelerate the market growth.
 

U.S. dominated the North America avidin market with a revenue of USD 62.7 million in 2022 and is slated to observe a significant pace from 2023 - 2032. The dominance of the country can be attributed to several factors such as the demand for reliable & accurate diagnostic solutions from the highly advanced diagnostic & healthcare industry in North America. Avidin is used in diagnostic tests, immunoassays, and other medical research applications.
 

The rising focus on personalized medicine, point-of-care testing, and disease detection is propelling the demand for avidin in the diagnostic & healthcare sector. North America is a major hub of the global biopharmaceutical industry owing to the presence of several biopharmaceutical companies in the region. Avidin is used in biopharmaceutical production processes including protein purification, where it plays a crucial role in ensuring the quality & purity of biopharmaceutical products. The growing North America biopharmaceutical industry is augmenting the demand for avidin.
 

Avidin Market Share

Some of the major market players operating in the avidin market are

• Vector Laboratories
• Thermo Fisher Scientific
• Merck KGaA (Sigma-Aldrich)
• Aviva Systems Biology
• BioVectra
• Cell Signaling Technology
• Avidity

These players focus on strategic partnerships and new product launches & commercialization for market expansion. Furthermore, they heavily invest in research to introduce innovative products and garner maximum revenue in the market.

Avidin Industry News:

• In May 2021, Avidity expanded its avidin business owing to the increasing global demand for avidin.
   

This avidin market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Million & Tons) from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Type

• Avidin from chicken egg whites
• Streptavidin
• Recombinant avidin

By Grade

• Food grade avidin
• Pharmaceutical grade avidin
• Research grade avidin

By Application

• Food & beverage industry 
• Bakery & confectionery
• Dairy products
• Beverages
• Functional foods
• Others 
• Pharmaceutical
• Drug delivery systems
• Diagnostic assays
• Therapeutics
• Research & development
• Research & biotechnology 
• Molecular biology
• Protein purification
• Cell imaging & staining
• Immunohistochemistry

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Malaysia 
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE